Latest News
Via The Motley Fool · April 21, 2025
Via The Motley Fool · April 21, 2025
Rampant uncertainty regarding the future of AI has battered the chipmaker.
Via The Motley Fool · April 21, 2025
Among risky nuclear power stocks, one stock is less risky than most.
Via The Motley Fool · April 21, 2025
Erratic announcements from the Trump administration continue to spook an exodus of capital from asset markets.
Via Talk Markets · April 21, 2025

The Sword of Damocles hanging over the entire economy is policy uncertainty, for unfortunately obvious reasons.
Via Talk Markets · April 21, 2025
The market is unequivocally saying an economic slowdown is in the cards. You simply don’t get utilities and staples as the leaders in a strong tape.
Via Talk Markets · April 21, 2025
The selloff is quite broad-based, with every S&P 500 sector trading lower.
Via Talk Markets · April 21, 2025
Via The Motley Fool · April 21, 2025
Federal prosecutors alleged that Walgreens violated the Controlled Substances Act by repeatedly filling prescriptions flagged as potentially unlawful.
Via Stocktwits · April 21, 2025
The new price target implies a 26% upside to the company’s closing price of $2.38 on Thursday.
Via Stocktwits · April 21, 2025
Coca-Cola’s stock has surged nearly 16% year-to-date, while the benchmark Dow Jones and the S&P 500 have lost 11% and 13% during the same period, respectively.
Via Stocktwits · April 21, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill · April 21, 2025
Big Tech taught us that governing structures like centralization and the network effect. Netflix certainly fits the bill.
Via Talk Markets · April 21, 2025
Commodity trends shifted in Q1, with deflation in grains but a spike in coffee prices. Restaurant stocks lag historic EPS multiples, and investors now eye April demand and potential tariff impacts.
Via Benzinga · April 21, 2025
Walgreens settles with U.S. government for $300 million over allegations it filled unlawful opioid prescriptions.
Via Benzinga · April 21, 2025
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · April 21, 2025
Pfizer Inc (NYSE:PFE) is scheduled to release its first quarter 2025 earnings on 29 April.
Via Benzinga · April 21, 2025